Analytical Approach on NVIDIA Corporation (NASDAQ:NVDA)

Analysts are weighing in on how NVIDIA Corporation (NASDAQ:NVDA) , might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.4. The stock is rated as buy by 7 analysts, with 6 outperform and 12 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 20.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.37 a share, which would compare with $0.05 in the same quarter last year. They have a high estimate of $0.41 and a low estimate of $0.35. Revenue for the period is expected to total nearly $1.35B from $1.15B the year-ago period.

For the full year, 20.00 Wall Street analysts forecast this company would deliver earnings of 1.58 per share, with a high estimate of $1.83 and a low estimate of $1.42. It had reported earnings per share of $1.08 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $5.59B versus 5.01B in the preceding year.

The analysts project the company to maintain annual growth of around 22.43% percent over the next five years as compared to an average growth rate of 7.24% percent expected for its competitors in the same industry.

Among the 20 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for NVDA is $44.48 but some analysts are projecting the price to go as high as $56.00. If the optimistic analysts are correct, that represents a 18 percent upside potential from the recent closing price of $47.55. Some sell-side analysts, particularly the bearish ones, have called for $30.00 price targets on shares of NVIDIA Corporation (NASDAQ:NVDA) .

In the last reported results, the company reported earnings of $0.05 per share, while analysts were calling for share earnings of $0.10. It was an earnings surprise of -50.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

NVIDIA Corporation operates as a visual computing company worldwide. It operates in two segments, GPU and Tegra Processor. The GPU segment offers processors, which include GeForce for PC gaming; Quadro for design professionals working in computer-aided design, video editing, special effects, and other creative applications; Tesla for deep learning, accelerated computing, and general purpose computing; and GRID for cloud-based streaming on gaming devices. The Tegra Processor segment provides processors that integrate a computer onto a single chip under the Tegra brand name; DRIVE automotive computers, which offer supercomputing capabilities; and tablet and portable devices for mobile gaming under the SHIELD name. The companys products are used in gaming, professional visualization, datacenter, and automotive markets. It sells its products primarily to original equipment manufacturers, original design manufacturers, system builders, motherboard manufacturers, add-in board manufacturers, and retailers/distributors. NVIDIA Corporation was founded in 1993 and is headquartered in Santa Clara, California.

Comcast Corporation (NASDAQ:CMCSA) Stock Price Will Hit 71.19:Analyst

Analysts are weighing in on how Comcast Corporation (NASDAQ:CMCSA)  , might perform in the near term. Wall Street analysts have a much favorable assessment of the stock, with a mean rating of 1.8. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 26.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.84 a share, which would compare with $0.84 in the same quarter last year. They have a high estimate of $0.89 and a low estimate of $0.80. Revenue for the period is expected to total nearly $19.11B from $18.74B the year-ago period.

For the full year, 27.00 Wall Street analysts forecast this company would deliver earnings of 3.54 per share, with a high estimate of $3.73 and a low estimate of $3.45. It had reported earnings per share of $3.24 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $79.25B versus 74.51B in the preceding year.

The analysts project the company to maintain annual growth of around 12.53% percent over the next five years as compared to an average growth rate of 15.16% percent expected for its competitors in the same industry.

Among the 27 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for CMCSA is $71.19 but some analysts are projecting the price to go as high as $84.00. If the optimistic analysts are correct, that represents a 33 percent upside potential from the recent closing price of $63.10. Some sell-side analysts, particularly the bearish ones, have called for $63.00 price targets on shares of Comcast Corporation (NASDAQ:CMCSA)  .

In the last reported results, the company reported earnings of $0.84 per share, while analysts were calling for share earnings of $0.84. It was an earnings surprise of 0.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Comcast Corporation operates as a media and technology company worldwide. It operates through Cable Communications, Cable Networks, Broadcast Television, Filmed Entertainment, and Theme Parks segments. The Cable Communications segment offers video, high-speed Internet, and voice services to residential and business customers under the XFINITY brand. This segment also provides business services, such as Ethernet network services; cellular backhaul services to mobile network operators; and advertising services on cable networks, as well as on other platforms, such as digital, radio, and print media. The Cable Networks segment operates national cable networks, which provide entertainment, news and information, and sports content; regional sports and news networks; international cable networks; and cable television studio production operations, as well as owns various digital media properties, which primarily include brand-aligned Websites. The Broadcast Television segment operates NBC and Telemundo broadcast networks, NBC and Telemundo owned local broadcast television stations, broadcast television studio production operations, and related digital media properties. The Filmed Entertainment segment produces, acquires, markets, and distributes live-action and animated filmed entertainment, principally under the Universal Pictures, Illumination, and Focus Features names. This segment also develops, produces, and licenses stage plays. The Theme Parks segment operates Universal theme parks in Orlando, Florida, as well as in Hollywood, California; Universal studios theme park in Osaka, Japan; Wet n Wild, a water park in Orlando, Florida; and CityWalk, a dining, retail, and entertainment complex. The company also owns the Philadelphia Flyers, as well as the Wells Fargo Center arena in Philadelphia, Pennsylvania; and operates arena management-related businesses. Comcast Corporation was founded in 1963 and is headquartered in Philadelphia, Pennsylvania.

How high can CVS Health Corp (NYSE:CVS) stock go’ Analysts hold 123.00

Analysts are weighing in on how CVS Health Corp (NYSE:CVS), might perform in the near term. Wall Street analysts have a much favorable assessment of the stock, with a mean rating of 1.8. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 24.00 analysts offering adjusted EPS forecast have a consensus estimate of $1.30 a share, which would compare with $1.22 in the same quarter last year. They have a high estimate of $1.32 and a low estimate of $1.28. Revenue for the period is expected to total nearly $44.30B from $37.17B the year-ago period.

For the full year, 25.00 Wall Street analysts forecast this company would deliver earnings of 5.83 per share, with a high estimate of $5.90 and a low estimate of $5.79. It had reported earnings per share of $5.16 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $181.34B versus 153.29B in the preceding year.

The analysts project the company to maintain annual growth of around 14.93% percent over the next five years as compared to an average growth rate of 11.96% percent expected for its competitors in the same industry.

Among the 20 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for CVS is $113.95 but some analysts are projecting the price to go as high as $123.00. If the optimistic analysts are correct, that represents a 29 percent upside potential from the recent closing price of $95.53. Some sell-side analysts, particularly the bearish ones, have called for $105.00 price targets on shares of CVS Health Corp (NYSE:CVS).

In the last reported results, the company reported earnings of $1.22 per share, while analysts were calling for share earnings of $1.20. It was an earnings surprise of 1.70%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS Pharmacy, CVS Specialty, Accordant, SilverScript, NovoLogix, Coram, Navarro Health Services, and Advanced Care Scripts names. As of December 31, 2015, it operated 24 retail specialty pharmacy stores, 11 specialty mail order pharmacies and 5 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. It operates 9,655 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 32 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Centurylink (NYSE:CTL) has54 percent upside potential

Analysts are weighing in on how Centurylink Inc (NYSE:CTL), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.9. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 15.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.59 a share, which would compare with $0.55 in the same quarter last year. They have a high estimate of $0.62 and a low estimate of $0.57. Revenue for the period is expected to total nearly $4.40B from $4.42B the year-ago period.

For the full year, 14.00 Wall Street analysts forecast this company would deliver earnings of 2.58 per share, with a high estimate of $2.65 and a low estimate of $2.52. It had reported earnings per share of $2.71 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $17.59B versus 17.90B in the preceding year.

The analysts project the company to maintain annual growth of around 0.23% percent over the next five years as compared to an average growth rate of 6.40% percent expected for its competitors in the same industry.

Among the 14 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for CTL is $29.71 but some analysts are projecting the price to go as high as $42.00. If the optimistic analysts are correct, that represents a 54 percent upside potential from the recent closing price of $27.24. Some sell-side analysts, particularly the bearish ones, have called for $22.00 price targets on shares of Centurylink Inc (NYSE:CTL).

In the last reported results, the company reported earnings of $0.55 per share, while analysts were calling for share earnings of $0.60. It was an earnings surprise of -8.30%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

CenturyLink, Inc. provides various communications services to residential, business, wholesale, and governmental customers in the United States. It operates through two segments, Business and Consumer. The company offers high-speed Internet services, which allow customers to connect to the Internet through their existing telephone lines or fiber-optic cables; multi-protocol label switching, a data networking technology to support real-time voice and video; and private line services for the transmission of data between sites. It also provides Ethernet services, including point-to-point and multi-point equipment configurations that facilitate data transmissions across metropolitan areas and wide area networks (WAN); colocation services that enable its customers to install their own information technology (IT) equipment; and managed hosting services comprising cloud and traditional computing, application management, back-up, storage, and other services. In addition, the company offers video entertainment services and satellite digital television; Voice over Internet Protocol, a real-time, two-way voice communication service; and managed services that consist of network, hosting, cloud, and IT services. Further, it provides local calling, long-distance voice, integrated services digital network, WAN, and switched access services; and data integration, which includes the sale of telecommunications equipment and providing network management, installation, and maintenance of data equipment, and the building of proprietary fiber-optic broadband networks. Additionally, the company leases and subleases space in its office buildings, warehouses, and other properties. As of December 31, 2015, it served approximately 6 million high-speed Internet subscribers and 285 thousand television subscribers; and operated 59 data centers in North America, Europe, and Asia. CenturyLink, Inc. was founded in 1968 and is headquartered in Monroe, Louisiana.

Analyst Review Alert: MGM Resorts International (NYSE:MGM)

Analysts are weighing in on how MGM Resorts International (NYSE:MGM), might perform in the near term. Wall Street analysts have a much favorable assessment of the stock, with a mean rating of 1.9. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 12.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.25 a share, which would compare with $0.17 in the same quarter last year. They have a high estimate of $0.48 and a low estimate of $0.11. Revenue for the period is expected to total nearly $2.34B from $2.39B the year-ago period.

For the full year, 16.00 Wall Street analysts forecast this company would deliver earnings of 0.69 per share, with a high estimate of $0.89 and a low estimate of $0.34. It had reported earnings per share of $0.55 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $9.14B versus 9.19B in the preceding year.

The analysts project the company to maintain annual growth of around 26.26% percent over the next five years as compared to an average growth rate of 17.04% percent expected for its competitors in the same industry.

Among the 15 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for MGM is $28.20 but some analysts are projecting the price to go as high as $32.00. If the optimistic analysts are correct, that represents a 32 percent upside potential from the recent closing price of $24.16. Some sell-side analysts, particularly the bearish ones, have called for $21.00 price targets on shares of MGM Resorts International (NYSE:MGM).

In the last reported results, the company reported earnings of $0.17 per share, while analysts were calling for share earnings of $0.11. It was an earnings surprise of 54.50%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

MGM Resorts International, through its wholly owned subsidiaries, owns and/or operates casino resorts in the United States and China. The company operates through two segments, Wholly Owned Domestic Resorts and MGM China. Its casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. Its casino operations include various slots, table games, and race and sports book wagering. The company operates 12 wholly owned resorts in the United States; and MGM Macau resort and casino in China, as well as develops an integrated casino, hotel, and entertainment resort on the Cotai Strip, Macau. The company also owns and operates Shadow Creek golf course, Primm Valley Golf Club, and Fallen Oak golf course. The company serves premium gaming customers; leisure and wholesale travel customers; business travelers; and group customers, including conventions, trade associations, and small meetings. The company was formerly known as MGM MIRAGE and changed its name to MGM Resorts International in June 2010. MGM Resorts International was founded in 1986 and is based in Las Vegas, Nevada.

Analyst Review Alert: AbbVie Inc (NYSE:ABBV)

Analysts are weighing in on how AbbVie Inc (NYSE:ABBV) , might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.3. The stock is rated as buy by 0 analysts, with 0 outperform and 0 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 17.00 analysts offering adjusted EPS forecast have a consensus estimate of $1.20 a share, which would compare with $1.08 in the same quarter last year. They have a high estimate of $1.27 and a low estimate of $1.16. Revenue for the period is expected to total nearly $6.20B from $5.48B the year-ago period.

For the full year, 20.00 Wall Street analysts forecast this company would deliver earnings of 4.76 per share, with a high estimate of $4.99 and a low estimate of $4.64. It had reported earnings per share of $4.29 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $25.56B versus 22.82B in the preceding year.

The analysts project the company to maintain annual growth of around 16.39% percent over the next five years as compared to an average growth rate of 16.98% percent expected for its competitors in the same industry.

Among the 18 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for ABBV is $70.00 but some analysts are projecting the price to go as high as $90.00. If the optimistic analysts are correct, that represents a 48 percent upside potential from the recent closing price of $60.90. Some sell-side analysts, particularly the bearish ones, have called for $47.00 price targets on shares of AbbVie Inc (NYSE:ABBV) .

In the last reported results, the company reported earnings of $1.08 per share, while analysts were calling for share earnings of $1.06. It was an earnings surprise of 1.90%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA an oral therapy for the treatment of chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for adults with genotype 1 chronic hepatitis, including those with compensated cirrhosis. It also provides Kaletra, an anti-HIV-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent respiratory syncytial virus infection in high risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, and endometriosis and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinsons disease; Sevoflurane, an anesthesia product for human use; TriCor, Trilipix, and Niaspan treat metabolic conditions characterized by high cholesterol and/or high triglycerides; and Zemplar to treat secondary hyperparathyroidism. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has strategic collaboration with C2N Diagnostics, Calico Life Sciences LLC, Infinity Pharmaceuticals, Inc., Ablynx NV, Galapagos NV, and Alvine Pharmaceuticals, Inc. The company was incorporated in 2012 and is based in North Chicago, Illinois.

Analyst Review Alert: TETRA Technologies, Inc. (NYSE:TTI)

Analysts are weighing in on how TETRA Technologies, Inc. (NYSE:TTI), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.1. The stock is rated as buy by 9 analysts, with 0 outperform and 2 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 11.00 analysts offering adjusted EPS forecast have a consensus estimate of $-0.18 a share, which would compare with $0.16 in the same quarter last year. They have a high estimate of $-0.14 and a low estimate of $-0.20. Revenue for the period is expected to total nearly $189.24M from $316.32M the year-ago period.

For the full year, 11.00 Wall Street analysts forecast this company would deliver earnings of -0.52 per share, with a high estimate of $-0.35 and a low estimate of $-0.79. It had reported earnings per share of $0.32 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $794.60M versus 1.13B in the preceding year.

The analysts project the company to maintain annual growth of around 53.85% percent over the next five years as compared to an average growth rate of 8.79% percent expected for its competitors in the same industry.

Among the 11 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for TTI is $7.86 but some analysts are projecting the price to go as high as $10.00. If the optimistic analysts are correct, that represents a 81 percent upside potential from the recent closing price of $5.51. Some sell-side analysts, particularly the bearish ones, have called for $6.00 price targets on shares of TETRA Technologies, Inc. (NYSE:TTI).

In the last reported results, the company reported earnings of $0.16 per share, while analysts were calling for share earnings of $0.01. It was an earnings surprise of 1,500.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

TETRA Technologies, Inc., together with its subsidiaries, operates as a diversified oil and gas services company. It operates through four divisions: Fluids, Production Testing, Compression, and Offshore. The Fluids division manufactures and markets clear brine fluids, additives, and associated products and services to the oil and gas industry for use in well drilling, completion, and workover operations in the United States, as well as in Latin America, Europe, Asia, the Middle East, and Africa. This segment also markets liquid and dry calcium chloride products; and provides water management services for oil and gas operators. The Production Testing division provides frac flowback, production well testing, offshore rig cooling, and other associated services in oil and gas producing regions in the United States, Mexico, and Canada, as well as in various basins in South America, Africa, Europe, the Middle East, and Australia. The Compression division provides compression services and equipment for natural gas and oil production, gathering, transportation, processing, and storage operating in onshore producing regions of the United States, as well as in Mexico, Canada, and Argentina. The Offshore division offers downhole and subsea services, such as well plugging, and abandonment and workover services; decommissioning and construction services through heavy lift barges and various cutting technologies; and conventional and saturation diving services. TETRA Technologies, Inc. was founded in 1981 and is headquartered in The Woodlands, Texas.

How high can Noble Corporation Ordinary Shares (UK) (NYSE:NE) stock go’ Analysts hold 20.00

Analysts are weighing in on how Noble Corporation Ordinary Shares (UK) (NYSE:NE), might perform in the near term. Wall Street analysts have a unfavorable assessment of the stock, with a mean rating of 3.2. The stock is rated as buy by 7 analysts, with 2 outperform and 15 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 31.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.19 a share, which would compare with $0.64 in the same quarter last year. They have a high estimate of $1.86 and a low estimate of $-0.12. Revenue for the period is expected to total nearly $551.65M from $793.56M the year-ago period.

For the full year, 35.00 Wall Street analysts forecast this company would deliver earnings of 0.54 per share, with a high estimate of $2.12 and a low estimate of $-0.24. It had reported earnings per share of $2.60 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $2.16B versus 3.21B in the preceding year.

The analysts project the company to maintain annual growth of around -58.85% percent over the next five years as compared to an average growth rate of 8.79% percent expected for its competitors in the same industry.

Among the 31 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for NE is $9.20 but some analysts are projecting the price to go as high as $20.00. If the optimistic analysts are correct, that represents a 125 percent upside potential from the recent closing price of $8.88. Some sell-side analysts, particularly the bearish ones, have called for $2.00 price targets on shares of Noble Corporation Ordinary Shares (UK) (NYSE:NE).

In the last reported results, the company reported earnings of $0.64 per share, while analysts were calling for share earnings of $0.52. It was an earnings surprise of 23.10%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

Noble Corporation plc operates as an offshore drilling contractor for the oil and gas industry worldwide. It owns and operates a fleet of mobile offshore drilling units. As of February 25, 2016, the company operated a fleet of 30 drilling rigs consisted of 14 jackups, 8 drillships, and 8 semisubmersibles, which included 1 high-specification, harsh environment jackup under construction. Noble Corporation plc was founded in 1921 and is headquartered in London, the United Kingdom.

Analyst Activity: MGIC Investment (NYSE:MTG)

Analysts are weighing in on how MGIC Investment Corp. (NYSE:MTG), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.2. The stock is rated as buy by 7 analysts, with 3 outperform and 6 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 14.00 analysts offering adjusted EPS forecast have a consensus estimate of $0.20 a share, which would compare with $0.28 in the same quarter last year. They have a high estimate of $0.22 and a low estimate of $0.19. Revenue for the period is expected to total nearly $255.14M from $243.13M the year-ago period.

For the full year, 12.00 Wall Street analysts forecast this company would deliver earnings of 0.79 per share, with a high estimate of $0.88 and a low estimate of $0.75. It had reported earnings per share of $1.09 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $1.03B versus 1.04B in the preceding year.

The analysts project the company to maintain annual growth of around 5.14% percent over the next five years as compared to an average growth rate of 9.32% percent expected for its competitors in the same industry.

Among the 12 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for MTG is $9.33 but some analysts are projecting the price to go as high as $12.00. If the optimistic analysts are correct, that represents a 102 percent upside potential from the recent closing price of $5.93. Some sell-side analysts, particularly the bearish ones, have called for $7.50 price targets on shares of MGIC Investment Corp. (NYSE:MTG).

In the last reported results, the company reported earnings of $0.28 per share, while analysts were calling for share earnings of $0.23. It was an earnings surprise of 21.70%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

MGIC Investment Corporation, through its subsidiaries, provides private mortgage insurance and ancillary services to lenders and government sponsored entities in the United States. The company offers primary mortgage insurance that provides mortgage default protection on individual loans, as well as covers unpaid loan principal, delinquent interest, and various expenses associated with the default and subsequent foreclosure. It also provides contract underwriting services; and other services for the mortgage finance industry, such as analysis of loan originations and portfolios, and mortgage lead generation services. In addition, the company participates in external reinsurance arrangements and captive mortgage reinsurance arrangements. It serves originators of residential mortgage loans, including savings institutions, commercial banks, mortgage brokers, credit unions, mortgage bankers, and other lenders. The company was founded in 1957 and is headquartered in Milwaukee, Wisconsin.

Analyst Activity: United Continental Holdings Inc (NYSE:UAL)

Analysts are weighing in on how United Continental Holdings Inc (NYSE:UAL), might perform in the near term. Wall Street analysts have a much less favorable assessment of the stock, with a mean rating of 2.1. The stock is rated as buy by 7 analysts, with 3 outperform and 5 hold rating. The rating score is on a scale of 1 to 5 where 1 stands for strong buy and 5 stands for strong sell.

For the current quarter, the 15.00 analysts offering adjusted EPS forecast have a consensus estimate of $2.43 a share, which would compare with $3.31 in the same quarter last year. They have a high estimate of $2.60 and a low estimate of $2.30. Revenue for the period is expected to total nearly $9.34B from $9.91B the year-ago period.

For the full year, 15.00 Wall Street analysts forecast this company would deliver earnings of 8.15 per share, with a high estimate of $9.03 and a low estimate of $6.85. It had reported earnings per share of $11.88 in the corresponding quarter of the previous year. Revenue for the period is expected to total nearly $36.40B versus 37.86B in the preceding year.

The analysts project the company to maintain annual growth of around 3.33% percent over the next five years as compared to an average growth rate of 18.20% percent expected for its competitors in the same industry.

Among the 14 analysts Data provided by Thomson/First Call tracks, the 12-month average price target for UAL is $64.71 but some analysts are projecting the price to go as high as $79.00. If the optimistic analysts are correct, that represents a 89 percent upside potential from the recent closing price of $41.83. Some sell-side analysts, particularly the bearish ones, have called for $54.00 price targets on shares of United Continental Holdings Inc (NYSE:UAL).

In the last reported results, the company reported earnings of $3.31 per share, while analysts were calling for share earnings of $3.31. It was an earnings surprise of 0.00%percent. In the matter of earnings surprises, the term Cockroach Effect is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.

United Continental Holdings, Inc., together with its subsidiaries, provides air transportation services in North America, the Asia-Pacific, Europe, the Middle East, Africa, and Latin America. The company transports people and cargo through its mainline and regional operations. As of December 31, 2015, it operated 1,236 aircraft. United Continental Holdings, Inc. also sells fuel; and offers catering, ground handling, and maintenance services for third parties. The company was formerly known as UAL Corporation and changed its name to United Continental Holdings, Inc. in October 2010. United